Scott Kellen - CFO and Secretary, Diamedica Therapeutics Inc

As of June 2, 2022


What is Scott Kellen's Net Worth?

The current estimated net worth of Diamedica Therapeutics Inc's CFO and Secretary, Scott Kellen, is estimated to be about $55.5K . Scott Kellen owns about 22,290 units of Diamedica Therapeutics Inc common stock. In the last 4 years at Diamedica Therapeutics Inc, Scott Kellen has sold an estimated value of $0 worth.

What is Scott Kellen's Past Insider Trading?

Scott Kellen's largest purchase order was 10,000 units , worth over $31.46K on August 16, 2021. In total, Scott Kellen has made about 9 transactions over 4 years of their time at Diamedica Therapeutics Inc. Scott Kellen usually trades in June, with the busiest year in 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Scott Kellen's Salary in 2020?

As CFO and Secretary of Diamedica Therapeutics Inc, Scott Kellen has a total base salary of $276,075 . Scott Kellen received compensation valued at about $489,303 in 2020 after becoming CFO and Secretary. The vast majority of their compensation came in the form of option awards of $119,140 , other earnings, plans or compensations of $79,238 , and other compensation of $14,850 .

What is Scott Kellen's' Mailing Address?

  • Mailing address is 3405 Annapolis Lane Suite 200 Minneapolis MN 55447 MN

Diamedica Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick Pauls 2020 $455,013 - $190,624 $217,716 $14,850 $878,203
Rick Pauls 2019 $420,000 - $890,736 $178,000 $14,650 $733,707
Scott Kellen 2020 $276,075 - $119,140 $79,238 $14,850 $489,303
Scott Kellen 2019 $262,500 - $336,557 $64,800 $13,950 $677,807
Harry Alcorn, Jr., Pharm.D. 2020 $291,413 - $119,140 $83,662 $14,850 $509,065
Harry Alcorn, Jr., Pharm.D. 2019 $273,750 - $421,750 $68,400 $14,400 $778,300
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1401040/000143774921014066/dmtp20210406_def14a.htm

What are Diamedica Therapeutics Inc's Past Insider Trades?

Diamedica Therapeutics Inc's most recent insider trade came on September 15, 2021 by Harry Alcorn Jr who bought 15,000 units worth $56.96K . In the last 3 years, insiders at Diamedica Therapeutics Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Richard Pilnik, Director,  Scott Kellen, CFO and Secretary,  and Harry Alcorn Jr, SVP .

DiaMedica Therapeutics Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1